SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
FDA Releases Risk Summaries For Newer Drugs
June 16, 2010
 · 
1 min read
Drug Development
Common Blood Pressure Drugs May Raise Cancer Risk, Case Western Reserve University Study
June 14, 2010
 · 
1 min read
Drug Development
Major Birth Defects Tied To Common Epilepsy Drug, Study in New England Journal of Medicine
June 10, 2010
 · 
1 min read
Drug Development
Common Pain Relievers Raise Heart Risk for Healthy Folks, Gentofte University Hospital Study
June 9, 2010
 · 
1 min read
Drug Development
San Diego’s Somaxon Pharmaceuticals, Inc. Readies to Wake Up Market for New Sleeping Pill
March 29, 2010
 · 
1 min read
Drug Development
New Study Refutes Bone Drugs’ Link To Fractures; Benefits Of Boniva, Fosamax And Reclast Far Outweigh Any Risk, University of California, San Francisco (UCSF) Experts Say
March 25, 2010
 · 
1 min read
Drug Development
Octreotide Acetate (Sandostatin) Does Not Prevent Treatment-Induced Diarrhea In Anorectal Cancer, Radiation Therapy Oncology Group Research
March 25, 2010
 · 
1 min read
Drug Development
Asthma May Respond to Statins, Too, Beth Israel Deaconess Medical Center Study
March 1, 2010
 · 
1 min read
Bookmark and Share
Drug Development
Common Cholesterol Drugs, Statins, Fight Cataracts, Too, Tel Aviv University Study
February 12, 2010
 · 
1 min read
Bookmark and Share
Drug Development
Common Anti-Inflammatory Drug Could Help Prevent Skin Cancers, Stanford University Researcher Says
January 5, 2010
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
eClinicalHealth Celebrates 5 Years In Business Supporting Direct-to-Patient Research Models For Clinical Trials
March 27, 2017
 · 
1 min read
Drug Development
Pfizer Receives Positive CHMP Opinion For TRUMENBA For Prevention Of Meningococcal Group B Disease
March 24, 2017
 · 
10 min read
Drug Development
EMA’s CHMP Recommends Approval Of Merck & Co.’s KEYTRUDA (Pembrolizumab) For The Treatment Of Patients With Relapsed Or Refractory Classical Hodgkin Lymphoma
March 24, 2017
 · 
18 min read
Drug Development
Horizon Pharma To Present Data On RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For Urea Cycle Disorder Patients Aged Two Months To Two Years
March 22, 2017
 · 
6 min read
Drug Development
Prime Therapeutics Study Finds 97 Percent Of Hepatitis C Patients Cured With Harvoni Treatment
March 21, 2017
 · 
1 min read
Drug Development
Boehringer Ingelheim Release: Uninterrupted Pradaxa (Dabigatran Etexilate Mesylate) Showed Less Major Bleeding Than Warfarin In Atrial Fibrillation Patients Undergoing Catheter Ablation
March 20, 2017
 · 
10 min read
Drug Development
New Analysis Shows Novartis AG Entresto Improves Glycemic Control In Reduced Ejection Fraction Heart Failure Patients With Diabetes
March 20, 2017
 · 
12 min read
Drug Development
AstraZeneca PLC’s Diabetes Med Cuts Death Rates in Real-World Trial
March 20, 2017
 · 
7 min read
Drug Development
Horphag Release: Study Shows Pycnogenol Normalizes Cardiovascular Risk Factors In Perimenopausal Women
March 16, 2017
 · 
4 min read
Business
Oncolytics Biotech Inc. Enters Into First-In-Class Collaboration With Myeloma UK And Celgene Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma
March 16, 2017
 · 
6 min read
Drug Development
Data From BioTime’s Opregen Trial In Dry-AMD To Be Presented At Association for Research in Vision & Ophthalmology On May 8
March 15, 2017
 · 
6 min read
Drug Development
Amgen Release: Repatha (Evolocumab) Four-Year Open-Label Follow-Up Study Published In ‘JAMA Cardiology’
March 15, 2017
 · 
14 min read
Drug Development
Elite Pharma Initiates Pivotal Bioequivalence Fed Study For Reformulated SequestOx
March 13, 2017
 · 
4 min read
Drug Development
The OHSU Knight Cancer Institute Release: “The New England Journal of Medicine” Publishes Long-Term Results Of Gleevec® For Patients With Chronic Myeloid Leukemia
March 9, 2017
 · 
4 min read
Drug Development
Novartis AG’ Cosentyx Shows Almost All Psoriasis Patients Rapidly Regain Skin Clearance Following A Treatment Pause
March 6, 2017
 · 
13 min read
Drug Development
New Data Demonstrate Sandoz Proposed Biosimilar Adalimumab Has Equivalent Efficacy To Reference Medicine
March 6, 2017
 · 
6 min read
Drug Development
Celgene Release: Oral OTEZLA (Apremilast) Demonstrated Significant Improvement Versus Placebo In Trial Of Patients With Moderate Plaque Psoriasis Who Were Naïve To Systemic And Biologic Therapy
March 6, 2017
 · 
8 min read
Drug Development
New Head-To-Head Data Shows Significantly Higher Response Rates For Eli Lilly ‘s Taltz (Ixekizumab) Compared To Stelara (Ustekinumab) In Patients With Moderate-To-Severe Plaque Psoriasis
March 6, 2017
 · 
8 min read
Drug Development
Celgene To Present New Data From Clinical Trials On Oral OTEZLA (Apremilast) At American Academy of Dermatology Congress
March 3, 2017
 · 
10 min read
Drug Development
Amgen Release: BLINCYTO (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy
March 2, 2017
 · 
20 min read
Load More